{"id":"W2175453042","doi":"10.1007/s10549-015-3633-7","title":"Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Medical Research Council; Eisai; Celgene","keywords":"Capecitabine; Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Nausea; Breast cancer; Quality of life (healthcare); Randomized controlled trial; Oncology; Cancer; Surgery; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002126532,0.001125854,0.002563509,0.0003328866,0.0003508093,0.0009219284,0.0005113027,0.001008861,0.003214441],"category_scores_gemma":[0.001221876,0.0003818561,0.001747464,0.00045829,0.0007805229,0.0006595395,0.0003180405,0.002078258,0.0004716696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007949974,"about_ca_system_score_gemma":0.001009856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004961438,"about_ca_topic_score_gemma":0.00165074,"domain_scores_codex":[0.9992118,0.0004936553,0.00004644439,0.00009568328,0.00005582929,0.00009655899],"domain_scores_gemma":[0.9994099,0.0001508654,0.0001638173,0.00003468649,0.00003158096,0.0002091981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9655637,0.01020593,0.002349023,0.0004328478,0.0007097895,0.00006637898,0.00005853931,0.0003637284,0.003245053,0.00006042607,0.0004854735,0.01645918],"study_design_scores_gemma":[0.835858,0.1565558,0.005773938,0.00002872826,0.0003360382,0.0000441241,0.00002485719,0.0004528257,0.0003794067,0.0001024718,0.0004320557,0.00001179184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933591,0.002823953,0.0002089437,0.0003567091,0.000130818,0.001894735,0.0003802397,0.00003041373,0.0008150391],"genre_scores_gemma":[0.9918947,0.00159376,0.0007072467,0.0007282066,0.0001729866,0.003387551,0.0007385724,0.000008209456,0.0007686936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003214441,"threshold_uncertainty_score":0.01124632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1701282498210228,"score_gpt":0.486875781200225,"score_spread":0.3167475313792022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}